Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Envisioning Minimally Disruptive Opioid Use Disorder Care
Honora Englander, Jessica Gregg, Ximena A. Levander
Journal of General Internal Medicine (2022) Vol. 38, Iss. 3, pp. 799-803
Open Access | Times Cited: 23

Showing 23 citing articles:

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
Christian Heidbreder, Paul J. Fudala, Mark K. Greenwald
Drug and Alcohol Dependence Reports (2023) Vol. 6, pp. 100133-100133
Open Access | Times Cited: 30
Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study
Thomas J. Stopka, Angela T. Estadt, Gillian Leichtling, et al.
Social Science & Medicine (2024) Vol. 346, pp. 116660-116660
Closed Access | Times Cited: 13
Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl
Honora Englander, Ashish P. Thakrar, Sarah M. Bagley, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 691-691
Closed Access | Times Cited: 10
Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement
Jennifer McNeely, Scarlett S. Wang, Yasna Rostam‐Abadi, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1106-1106
Closed Access | Times Cited: 9
Comparing methadone policy and practice in France and the US: Implications for US policy reform
Honora Englander, Mathieu Chappuy, Noa Krawczyck, et al.
International Journal of Drug Policy (2024) Vol. 129, pp. 104487-104487
Closed Access | Times Cited: 8
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
Alison E. Adams, Sarin Blawatt, Tianna Magel, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17
Experiences of Aging with Opioid Use Disorder and Comorbidity in Opioid Treatment Programs: A Qualitative Analysis
Benjamin H. Han, Mirella A. Orozco, Mari Miyoshi, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 9, pp. 1673-1680
Open Access | Times Cited: 5
Methadone’s Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction)
Leslie W. Suen, Michael Incze, Caty Simon, et al.
Substance Use & Addiction Journal (2024) Vol. 45, Iss. 3, pp. 337-345
Closed Access | Times Cited: 5
“Just Be Relentless,” Lessons Learned from In-Hospital Addiction Consult Service Implementation
Beth E. Williams, Alisa Patten, Linda Peng, et al.
Journal of General Internal Medicine (2025)
Closed Access
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder
Matthew Heshmatipour, Tyler M. Duvernay, Desislava Z. Hite, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
“Un attracteur de soins”: Bringing People Into Care. Interdisciplinary Health Care Professionals’ Attitudes Toward Opioid Agonist Therapy in France: a Qualitative Study with Implications for the United States
Honora Englander, Benjamin Rolland, Marie Jauffret‐Roustide
Substance Abuse (2025)
Closed Access
Opioid Use Disorder Medications After Hospitalization—Rethinking Engagement in Care
Honora Englander
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1115-1115
Closed Access | Times Cited: 3
“Come try it out. Get your foot in the door:” Exploring patient perspectives on low-barrier treatment for opioid use disorder
Margaret Lowenstein, Matthew P. Abrams, Molly Crowe, et al.
Drug and Alcohol Dependence (2023) Vol. 248, pp. 109915-109915
Open Access | Times Cited: 8
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
Arthur Robin Williams, Christopher Rowe, Ryan Gallagher, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 7, pp. e232247-e232247
Open Access | Times Cited: 5
“Get in and get out, get on with life”: Patient and provider perspectives on methadone van implementation for opioid use disorder treatment
Leslie W. Suen, Scott Steiger, Brad Shapiro, et al.
International Journal of Drug Policy (2023) Vol. 121, pp. 104214-104214
Open Access | Times Cited: 5
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities
Zoe Friedmann, H.J. Kinkel, C. Kühner, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Medication safety, privacy, and stigma: A qualitative study of pharmacy opioid agonist treatment disruptions and adaptations in the 2022 Northern Rivers floods, Australia
Theresa Caruana
International Journal of Disaster Risk Reduction (2024) Vol. 101, pp. 104244-104244
Open Access | Times Cited: 1
“I still can feel the sickness”: Withdrawal experiences of people on methadone maintenance treatment
David Frank, Alex S. Bennett, Charles M. Cleland, et al.
Journal of Substance Use and Addiction Treatment (2024) Vol. 170, pp. 209616-209616
Closed Access | Times Cited: 1
Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021
Riley D. Shearer, Benjamin A. Howell, Utsha G. Khatri, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 8, pp. 100179-100179
Open Access | Times Cited: 2
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis
Jessica V. Couch, Mackenzie Whitcomb, Bradley M. Buchheit, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Patient experiences of buprenorphine dispensing from a mobile medical unit
Sarah Messmer, Abigail T. Elmes, Alexander F. Infante, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access
How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain
Katie Fitzgerald Jones, Kevin T. Liou, Rebecca L. Ashare, et al.
Journal of Clinical Oncology (2024)
Closed Access
Hospital Provider’s Perspectives on MOUD Initiation and Continuation After Inpatient Discharge
Riley D. Shearer, Honora Englander, Hildi Hagedorn, et al.
Journal of General Internal Medicine (2024)
Open Access
Page 1

Scroll to top